Join CBSET at the 7th Annual DeviceTalks Boston conference, October 8-10, 2018, at the Westin Boston Waterfront, Boston, MA.
This year’s event will feature three tracks of curated content, focusing on issues confronting medtech companies across Boston and beyond, drilling down into the hottest new tech that’s changing medtech; and highlighting issues for emerging medtech companies seeking investment for growth.
If you would like to meet up with us at the event, please contact us.
Related CBSET Services:
by Michael Naimark, MS, Director of Business Development at CBSET, Inc.
Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings. by Tzafriri AR, Garcia-Polite F, Li X, Keating J, Balaguer JM, Zani B, Bailey L, Markham P, Kiorpes TC, Carlyle W, Edelman ER. Journal of Controlled Release, March 28, 2018, Volume 274, Pages 102-108.
Intracochlear Drug Delivery Systems: A Novel Approach Whose Time Has Come. Peppi M, Marie A, Belline C, Borenstein JT. Expert Opinion on Drug Delivery, Volume 15, Issue 4, March 9, 2018, Pages 319-324.
A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Indolfi L, Ligorio M, Ting DT, Xega K, Tzafriri AR, Bersani F, Aceto N, Thapar V, Fuchs BC, Deshpande V, Baker AB, Ferrone CR, Haber DA, Langer R, Clark JW, Edelman ER. Biomaterials, Volume 93, July 2016, Pages 71-82.